MeSH D004653 - empyema
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Wyeth | Penicillin g benzathine | Bicillin | 1982-01-01 | |||
| Penicillin g benzathine | Bicillin L-a | 1982-01-01 | ||||
| Penicillin g | Penicillin G Potassium | 1982-01-01 | ||||
| King Pharmaceuticals | Penicillin g benzathine, Penicillin g procaine | Bicillin C-r | 1982-01-01 | |||
| Penicillin g benzathine | Bicillin L-a | 1982-01-01 | ||||
| Penicillin g procaine | Penicillin G Procaine | 1982-01-01 | ||||
| Pfizer | Penicillin g procaine | Penicillin G Procaine | 1982-01-01 | |||
| Penicillin g procaine | Pfizerpen-as | 1982-01-01 | ||||
| Penicillin g | Penicillin G Potassium | 1982-01-01 | ||||
| Penicillin g | Pfizerpen | 1982-01-01 | ||||
| Penicillin g | Pfizerpen G | 1982-01-01 | ||||
| Eli Lilly | Penicillin g procaine | Duracillin A.s | 1982-01-01 | |||
| Penicillin g | Penicillin G Potassium | 1982-01-01 | ||||
| Pharmacia & Upjohn | Penicillin g | Penicillin G | 1982-01-01 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
50%1/2
Phase 3
80%4/5
Approved: 3Overall Success rate: 40%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use